labs

Hemoglobin

Hemoglobin

Longitudinal Data

Date Value Flag Context/Notes Source
2026-06-06 12.1 N KIMS — SLS method. Bill L042743426. RECOVERED TO NORMAL +0.8 from June 1. WBC 2500 (L — recovering), ANC 1240 (L — moderate neutropenia, improved from severe), Plt 241 (N). Hct 36.8% (N — borderline), RBC 3.82 (L), MCV 96.3 (H), RDW 17.2 (H — improved). Dr. Bijay. Collected 10:50 AM. raw/labs/2026-06-07_Ishamma_T_M_1.pdf
2026-06-01 11.3 L KIMS — SLS method. Bill L041256126. Dropped −0.7 from May 27. WBC 2200 (L — deepest nadir), ANC 990 (L — SEVERE NEUTROPENIA), Plt 252 (N — fully recovered). Hct 35.3% (L), RBC 3.53 (L), MCV 100 (H — macrocytosis worsening), RDW 18.3 (H). Dr. Bijay. Collected 11:11 AM. raw/labs/2026-06-01_Ishamma_T_M.pdf
2026-05-27 12.0 N (borderline) KIMS — SLS method. Bill L040020926. RECOVERED to normal threshold — first normal Hb since AML diagnosis. +0.4 from May 23. WBC 2400 (L — leukopenia), ANC 1460 (L — moderate neutropenia), Plt 107 (L). Hct 35.8% (just below normal), RBC 3.77 (L). Dr. Bijay. Collected 10:42 AM. raw/labs/20260527_Ishamma T M 1 5-27-2.pdf
2026-05-23 11.6 L KIMS — SLS method. Bill L038904126. WBC 3500 (L), ANC 2430 (N borderline), Plt 117 (L). Hct 35.6%, RBC 3.76 (L), MCV 94.7 (H), RDW 18.0 (H). Smear checked. Dr. Bijay. Collected 09:41 AM. raw/labs/20260527_Ishamma T M 5-27-1.pdf
2026-05-17 9.9 L KIMS — SLS method. Bill L037179526. SEVERE DROP −1.9 g/dL from May 11 (6 days). WBC 4600 (N), Plt 103 (L — continued thrombocytopenia), ANC 3400 (N). Hct 30%. Dr. Bijay. raw/labs/2026-05-17_Ishamma_T_M_1.pdf
2026-05-11 11.8 L KIMS — SLS method. Bill L035372426. Slight decrease from 11.9 (May 4). WBC 5700 (N), Plt 113 (L — new thrombocytopenia), ANC 3950 (N). Dr. Bijay Prabhakaran Nair. raw/labs/2026-05-11_Ishamma_T_M_A.pdf
2026-05-04 11.9 L KIMS — SLS method. Bill L033433126. Further improvement from Apr 27. WBC 4000 (recovered), Plt 213 (stable normal), ANC 2360 (recovered). raw/assets/2026-05-04_Ishamma_T_M.pdf
2026-04-27 11.4 L KIMS — SLS method. Bill L031606726. WBC 3000, Plt 196 (recovered), ANC 1990. raw/labs/20260427_Ishamma T M 1 ok.pdf
2026-04-20 11.4 L KIMS — SLS method. Bill L029731026. 20260420_Ishamma T M today.pdf
2026-04-13 10.5 L KIMS - Aza-Ven treatment Ishamma T M 1.pdf
2026-04-06 11.6 L KIMS Ishamma T M.pdf
2026-03-30 11.3 L KIMS Ishamma T M 2.pdf
2026-03-25 10.9 L KIMS Ishamma T M 1 2.pdf
2026-03-18 10.1 L KIMS Ishamma T M 1 3.pdf
2026-03-12 10.0 L KIMS Ishamma T M 1 4.pdf
2026-03-05 9.7 L KIMS Ishamma T M 3.pdf
2026-03-02 10.5 L KIMS Ishamma T M 4.pdf
2026-02-25 10.5 L KIMS Ishamma T M 5.pdf
2026-02-23 10.8 L DDRC Report For Accession No 4170ZB001398.pdf
2026-02-20 10.6 L DDRC - WBC critically low at 1600 4170ZB0011814170_849900t.pdf
2026-02-17 10.2 L KIMS Ishamma 1.pdf
2026-02-10 9.8 L KIMS Ishamma T M 6.pdf
2026-02-04 8.8 L KIMS Ishamma T M 1 5.pdf
2026-01-31 8.3 L KIMS Ishamma T M 7.pdf
2026-01-28 9.6 L KIMS Ishamma T M 1 6.pdf
2026-01-25 8.7 L KIMS Ishamma T M 8.pdf
2026-01-22 9.6 L KIMS Ishamma T M 9.pdf
2026-01-19 11.0 L KIMS Ishamma T M 1 7.pdf
2026-01-16 9.0 L KIMS Ishamma T M 10.pdf
2025-11-28 6.8 L KIMS - Nadir. Post-biopsy period File1000384802.pdf
2025-11-19 8.3 L DDRC - At AML diagnosis CCR_4182YK007572_296266q.pdf
2022-11-25 12.4 N JDC Lab (Jothydev's) — Colorimetric (Beer-Lambert's). Ref 12–16 g/dL. Normal — pre-AML baseline. raw/assets/20260429_IMG_9751.jpeg
2022-09-27 11.0 L DDRC SRL 4182VI0131054182_816476x.pdf

Trend Analysis

Hemoglobin reached its nadir of 6.8 g/dL in late November 2025, coinciding with the post-biopsy period around AML diagnosis. From that low point, there has been a gradual upward trend with Aza-Ven treatment, rising through the 8-9 range in January 2026 and into the 10-11 range by February-April 2026. Hemoglobin improved to 11.9 g/dL (May 4), then 11.8 g/dL (May 11), before dropping severely to 9.9 g/dL (May 17) — the cyclical myelosuppression nadir.

[!success] HEMOGLOBIN NORMALIZED: 11.3 → 12.1 g/dL (June 1 → June 6)
Hemoglobin has recovered to normal at 12.1 g/dL (+0.8 from June 1) — within reference range 12–15 g/dL. This is the second sustained normal hemoglobin since AML diagnosis (first was May 27 at 12.0 g/dL).

Recovery trajectory:
- May 17: 9.9 (nadir — severe anemia)
- May 23: 11.6 (+1.7 in 6 days)
- May 27: 12.0 (first normal, transient)
- June 1: 11.3 (−0.7 — dropped back to anemic)
- June 6: 12.1 (+0.8 — NORMAL, sustained)

Concurrent improvements:
- Hematocrit 36.8% — normalized to lower limit (36-47%), was 35.3% on June 1
- RBC 3.82 million/cumm — improved from 3.53 (June 1), still 0.1 below normal (3.80-4.80)
- MCV 96.3 fL — improved from 100 fL (June 1), macrocytosis decreased but still elevated (ref 82-92)
- RDW 17.2% — improved from 18.3% (June 1), anisocytosis improved but still elevated (ref 11.60-13.70)

Lineage recovery sequence confirmed:
- Platelet nadir (May 11) → Platelet recovery (June 1-6, now 241K stable)
- Hb nadir (May 17) → Hb recovery (June 6, now 12.1 NORMAL)
- WBC/ANC nadir (May 27-June 1) → WBC/ANC recovery (June 6, WBC 2500, ANC 1240 — moderate neutropenia, improving)

Anemia RESOLVED. Multi-lineage hematopoietic recovery confirmed across platelets, erythroid, and granulocyte lines. See Rbc Count, Platelet Count, Anc, Wbc, Aml.

**Prior Deterioration (May 11 → 17) — for historical context**

Hemoglobin dropped by 1.9 g/dL in 6 days (16% decline) as part of Aza-Ven cyclical nadir. Now resolved with recovery.

Cyclical pattern May 2026: Plt nadir May 11 (103-113K) → Hb/RBC nadir May 17 (9.9/3.17) → WBC/ANC nadir May 23-27 (WBC 3500/2400, ANC 2430/1460). Hb and RBC have recovered while ANC is at nadir — classic dissociated lineage kinetics of Aza-Ven myelosuppression.

Recovery pattern (April-early May): The May 4 improvement occurred concurrently with recovery in WBC (3000 → 4000) and ANC (1990 → 2360), suggesting coordinated hematopoietic recovery across multiple lineages after the late-April cyclical nadir.

Earliest confirmed normal: Hemoglobin was 12.4 g/dL in November 2022 at Jothydev's — within the normal reference range (12–16 g/dL). This is the patient's pre-illness confirmed-normal baseline.

Updated: 2026-05-27